Gossamer Bio Inc (NASDAQ:GOSS)
| 10.46 Delayed Data As of Jan 22 |  +0.30 / +2.95%Today’s Change | 7.52 Today|||52-Week Range 16.79 | +8.17% Year-to-Date |
Latest GOSS News | Press Releases
No recent news for Gossamer Bio Inc.
Today’s Trading
| Previous close | 10.16 |
| Today’s open | 10.16 |
| Day’s range | 10.07 - 10.46 |
| Volume | 6,397 |
| Average volume (3 months) | 815,639 |
| Market cap | $779.8M |
Data as of 3:59pm ET, 01/22/2021
Growth & Valuation
| Earnings growth (last year) | -47.64% |
| Earnings growth (this year) | -4.86% |
| Earnings growth (next 5 years) | +4.67% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 1.80 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AERIAerie Pharmaceutical... | +0.30 | +1.82% |
| ODTOdonate Therapeutics... | +0.81 | +4.17% |
| VNDAVanda Pharmaceutical... | -0.36 | -2.47% |
| MNKDMannKind Corp | +0.12 | +3.52% |
Data as of 3:59pm ET, 01/22/2021
Financials
| Next reporting date | March 19, 2021 |
| EPS forecast (this quarter) | -$0.79 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$180.3M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
